Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Pharma Tech

FDA approves Viatris’ Ryzumvi for adult presbyopia

Oct 19, 2026, 9:41 AM

Read Full Article → FDA approves Viatris’ Ryzumvi for adult presbyopia

FDA approves Viatris’ Ryzumvi for adult presbyopia

Translate article text

Choose a language and wait for the translated text.

The US FDA has approved Viatris' Ryzumvi (phentolamine ophthalmic solution 0.75%) to treat presbyopia in adults.

FDA approves Viatris’ Ryzumvi for adult presbyopia | PharmaVoice